Rozas C J, Goldman A L
Arch Intern Med. 1982 Jul;142(7):1287-91. doi: 10.1001/archinte.142.7.1287.
To determine the daily variability of spirometry, we performed spirometry on five consecutive days on 15 normal subjects and on 24 patients with chronic bronchitis. The patients with chronic bronchitis were divided into the following two groups: 13 with chronic airflow obstruction (forced expiratory volume in 1 s [FEV1] 80%, FEV1/forced vital capacity [FVC] ratio less than 75%) and 11 without airflow obstruction (FEV1 and FVC greater than 80%0. We attempted to control most of the factors known to affect spirometric variability. Our results indicate that the day-to-day FEV1 has to change by 17% and the FCV by 15% in patients with airflow obstruction before the change should be considered significant. In patients with nonobstructive chronic bronchitis or in normal subjects, a greater than 5% change should occur in FEV1 and FVC before considering the change to be significant.
为了确定肺活量测定的每日变异性,我们对15名正常受试者和24名慢性支气管炎患者连续五天进行了肺活量测定。慢性支气管炎患者被分为以下两组:13例有慢性气流受限(一秒用力呼气容积[FEV1]<80%,FEV1/用力肺活量[FVC]比值<75%),11例无气流受限(FEV1和FVC>80%)。我们试图控制已知会影响肺活量测定变异性的大多数因素。我们的结果表明,气流受限患者的FEV1每日变化必须达到17%,FVC每日变化必须达到15%,才能认为这种变化具有显著性。在非阻塞性慢性支气管炎患者或正常受试者中,FEV1和FVC的变化大于5%时,才考虑这种变化具有显著性。